Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 4,126,259 | 4,580,463 | 2,434,123 | 4,341,236 | 4,314,889 |
| Cost of Goods | 1,848,381 | 2,197,741 | 690,340 | 2,067,494 | 2,166,590 |
| Gross Profit | 2,277,878 | 2,382,722 | 1,743,783 | 2,273,742 | 2,148,299 |
| Operating Expenses | 2,049,840 | 1,402,973 | 1,233,523 | 1,360,837 | 1,465,790 |
| Operating Income | 228,419 | 980,490 | 510,601 | 913,399 | 683,099 |
| Interest Expense | 38,418 | 37,290 | 47,615 | 52,757 | 52,221 |
| Other Income | 131,488 | 110,723 | -11,663 | 93,068 | 153,579 |
| Pre-tax Income | 321,489 | 1,053,923 | 451,323 | 953,710 | 784,457 |
| Income Tax | 142,346 | 252,942 | 70,914 | 233,659 | 192,192 |
| Net Income Continuous | 179,143 | 800,981 | 380,409 | 720,051 | 592,265 |
| Net Income Discontinuous | 67,500 | N/A | N/A | N/A | N/A |
| Net Income | $246,643 | $800,981 | $627,107 | $720,051 | $592,265 |
| EPS Basic Total Ops | 0.16 | 0.51 | 0.40 | 0.46 | 0.38 |
| EPS Basic Continuous Ops | 0.11 | 0.51 | 0.24 | 0.46 | 0.38 |
| EPS Basic Discontinuous Ops | 0.05 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.16 | 0.51 | 0.40 | 0.46 | 0.38 |
| EPS Diluted Continuous Ops | 0.11 | 0.51 | 0.24 | 0.46 | 0.38 |
| EPS Diluted Discontinuous Ops | 0.05 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $479,005 | $1,293,145 | $662,714 | $1,204,860 | $960,026 |